Has Canada’s Biotech Moment Finally Arrived?
Cheryl Reicin was quoted in The Globe and Mail discussing the resurgence of the biotechnology sector and the opportunities it presents for Canadian life sciences companies.
Commenting on the factors driving biotechnology investment and dealmaking, Cheryl said, “The Big Pharmas are out there, they need to buy, they need to do licensing deals, they need a lot of shots on goal.”
Source